Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment
Human health risk assessment is historically built upon animal testing, often following Organisation for Economic Co-operation and Development (OECD) test guidelines and exposure assessments. Using combinations of human relevant in vitro models, chemical analysis and computational (in silico) approa...
Main Authors: | Elena Reale, Maryam Zare Jeddi, Alicia Paini, Alison Connolly, Radu Duca, Francesco Cubadda, Emilio Benfenati, Jos Bessems, Karen S. Galea, Hubert Dirven, Tiina Santonen, Holger M. Koch, Kate Jones, Craig Sams, Susana Viegas, Machera Kyriaki, Luca Campisi, Arthur David, Jean-Philippe Antignac, Nancy B Hopf |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Environment International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0160412024000606 |
Similar Items
-
Health Risk Assessment of Ortho-Toluidine Utilising Human Biomonitoring Data of Workers and the General Population
by: Pasi Huuskonen, et al.
Published: (2022-04-01) -
Development, testing, parameterisation, and calibration of a human PBK model for the plasticiser, di (2-ethylhexyl) adipate (DEHA) using in silico, in vitro and human biomonitoring data
by: Kevin McNally, et al.
Published: (2023-03-01) -
Development, testing, parameterisation, and calibration of a human PBPK model for the plasticiser, di-(2-ethylhexyl) terephthalate (DEHTP) using in silico, in vitro and human biomonitoring data
by: Kevin McNally, et al.
Published: (2023-02-01) -
A physiologically-based kinetic (PBK) model for work-related diisocyanate exposure: Relevance for the design and reporting of biomonitoring studies
by: B. Scholten, et al.
Published: (2023-04-01) -
Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics
by: Keyur R. Parmar, et al.
Published: (2023-06-01)